A high-stakes international legal dispute is unfolding between Guangdong Beautiful Health Co., Ltd and OC Oerlikon Corporation AG, focusing on complex corporate accountability and contractual obligations. The case centers on a €20 million transaction involving Teknoweb Materials SRL, an Oerlikon subsidiary that entered judicial liquidation in February 2024.
The dispute originated from a contract signed in October 2020 between Guangdong Beautiful Health and Teknoweb Materials for industrial machinery procurement. Following Teknoweb's judicial liquidation, Guangdong Beautiful Health is challenging Oerlikon's potential legal responsibility through corporate governance implications.
A critical conciliation hearing is scheduled for March 3, 2025, at the Justizgebäude Höfe in Switzerland. The proceedings, registered under case reference SHO 2025 27, will examine the extent of Oerlikon's operational involvement and potential liability in Teknoweb's financial challenges.
Dominique Calcò Labbruzzo, founder of the holistic law firm representing one party, emphasized the goal of efficiently resolving the matter through conciliation. The case highlights the increasingly complex landscape of international corporate accountability, where subsidiaries' actions can potentially implicate parent companies.
This legal proceeding underscores the intricate challenges multinational corporations face in managing cross-border business relationships and the potential legal risks inherent in global corporate structures.
